Resources

Publications

06/09/2025
- Oncology
Defining Non-Small Cell Lung Cancer Tumor Microenvironment Changes at Primary and Acquired Immune Checkpoint Inhibitor Resistance Using Clinical and Real-World Data
Cancer Research Communications
06/04/2025
- Oncology
A Concordance Study Among 26 NGS Laboratories Participating in the National Cancer Institute-Molecular Analysis for Therapy Choice (NCI-MATCH) Clinical Trial
Clinical Cancer Research
05/30/2025
- Oncology
Development and Validation of The Immune Profile Score (IPS), a Novel Multiomic Algorithmic Assay For Stratifying Outcomes in a Real-World Cohort of Patients With Advanced Solid Cancer Treated With Immune Checkpoint Inhibitors
The Journal for ImmunoTherapy of Cancer
05/28/2025
- Oncology
Outcomes Following First-Line Immune Checkpoint Inhibitors With or Without Chemotherapy Stratified by KRAS Mutational Status – a Real-World Analysis in Patients With Advanced NSCLC
Clinical Lung Cancer
05/22/2025
- Oncology
GEMINI-NSCLC Study – Integrated Longitudinal Multi-Omic Biomarker Profiling Study of Non-Small Cell Lung Cancer (NSCLC) Patients
ASCO 2025
05/22/2025
- Oncology
Genomic Landscape and Clinical Characteristics of Patients (Pts) With Neuroendocrine Prostate Cancer (NEPC) With or Without Aggressive Variant Prostate Cancer Characterized by Molecular Signature (AVPC-MS)
ASCO 2025
05/22/2025
- Oncology
Investigation of Liver-Specific Gene Expression Signatures in Prostate Cancers Prior to Liver Metastases
ASCO 2025
05/22/2025
- Oncology
A Natural Language Processing (NLP) Approach for Optical Character Recognition (OCR)-Resilient Extraction, Correction, and Structuring of Karyotype Data in Oncology Clinical Notes
ASCO 2025
05/22/2025
- Oncology
Real-World Evaluation of the Reduction in Complexity of Ordering DNA Sequencing Tests Through the Adoption of Fast Healthcare Interoperability Resources (FHIR) Standards
ASCO 2025
05/22/2025
- Oncology
Real-World Analyses To Evaluate the Role of TIGIT as a Target in First-Line (1L) Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinomas (GC/GEJC/EAC)
ASCO 2025

1 2 3